To assess the changes in macular and peripapillary retinal nerve fibre layer (RNFL) thickness in eyes with unilateral optic atrophy and to evaluate the relationship between retinal thickness and ...

The autosomal dominant optic atrophy (ADOA) treatment market is experiencing steady expansion, driven by growing disease awareness, advancements in diagnosis, and breakthrough therapies from key ...

Please provide your email address to receive an email when new articles are posted on . Band optic atrophy is described as a horizontal band of optic disc pallor, often associated with a contralateral ...

Optic atrophy is a degenerative disease of the optic nerve that leads to gradual damage to the retinal ganglion cells - the nerve cells that transmit visual signals from the retina to the brain. The ...

TOKYO — Sotos’ syndrome, an extremely rare genetic disorder characterized by excessive growth before and after birth, may be associated with optic disc pallor and retinal atrophy. A case report of a ...

Autosomal dominant optic atrophy (ADOA), the most common genetic optic neuropathy, is an insidious disease. It often presents slowly during childhood by way of blurry vision, trouble reading or ...

– Data provide insights that informed the Phase 1 study of STK-002 as a potential disease-modifying medicine for ADOA, including disease etiology, progression and clinical assessments – – ADOA is a ...

BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression ...

BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression ...

The autosomal dominant optic atrophy treatment market is experiencing significant expansion, driven by increasing disease awareness, rising prevalence, and R&D in precision medicine from key ...